Dupont Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,228
| Closed | -$115K | – | 1640 |
|
|
2022
Q2 | $115K | Hold |
2,228
| – | – | 0.01% | 1154 |
|
|
2022
Q1 | $162K | Sell |
2,228
-198
| -8% | -$14.4K | 0.01% | 1141 |
|
|
2021
Q4 | $287K | Sell |
2,426
-968
| -29% | -$115K | 0.01% | 990 |
|
|
2021
Q3 | $455K | Sell |
3,394
-5,919
| -64% | -$794K | 0.01% | 933 |
|
|
2021
Q2 | $1.51M | Sell |
9,313
-4,357
| -32% | -$706K | 0.04% | 438 |
|
|
2021
Q1 | $1.1M | Sell |
13,670
-12,011
| -47% | -$964K | 0.03% | 542 |
|
|
2020
Q4 | $1.4M | Sell |
25,681
-1,917
| -7% | -$104K | 0.03% | 438 |
|
|
2020
Q3 | $549K | Sell |
27,598
-1,849
| -6% | -$36.8K | 0.01% | 711 |
|
|
2020
Q2 | $619K | Sell |
29,447
-2,629
| -8% | -$55.3K | 0.01% | 681 |
|
|
2020
Q1 | $392K | Hold |
32,076
| – | – | 0.01% | 765 |
|
|
2019
Q4 | $471K | Buy |
32,076
+8,050
| +34% | +$118K | 0.01% | 871 |
|
|
2019
Q3 | $321K | Buy |
+24,026
| New | +$321K | 0.01% | 968 |
|